Megan Dwyer, MS, CGC, CGA-IGC Communications Committee member National Hereditary Cancer Week takes place from September 27 to October 3, with a focus on raising awareness of inherited cancer risk and promoting early detection through genetic testing and screening. A central part of this effort is cascade testing: testing family members after a cancer-related gene mutation is identified in a relative. Done well, it catches at-risk individuals before cancer develops, enabling

Jennifer Fijor, ARNP, CGA-IGC Communications Committee member The NCCN Guidelines for Genetic/Familial High-Risk Assessment were updated in June 2026, with real changes across colorectal, endometrial, gastric, and now esophageal cancer for the first time. Here's what changed, and where the field still doesn't agree: 1. Universal Lynch syndrome assessment expands, but it wasn't an easy vote Version 1.2026 now recommends universal Lynch syndrome assessment for all patients with

Ophir Gilad, MD - Communications Committee member If you missed our latest webinar, or would like to revisit the discussion, the full session is now available on-demand for CGA-IGC members. (Not yet a member? You can join here). This webinar featured Maegan E. Roberts, MS, CGC, Assistant Professor at The Ohio State University, who provided a practical guide to understanding variant summaries and reassessing assigned variant classifications. Ms. Roberts began by reviewing dif

Chandrika Kurpad MS, LCGC - CGA-IGC Communications Committee Member Synthesized from the CGA-IGC 2026 podcast series, Episode 4 featuring Kimberly Zayhowski, a certified genetic counselor and assistant program director at Boston University, and Dr. Iris Romero, a professor of OB/GYN at the University of Chicago who specializes in hereditary cancer prevention and LGBTQ+ health, in conversation with host Ying Lu, a GYN medical oncologist who leads the Inherited GYN Cancer Progr

Mehul Trivedi, MD - Communications Committee Member We heard from Dr. Namrata Setia from the University of Chicago and Dr. Paul Mansfield from MD Anderson Cancer Center, who shared their expertise on the pathology, surveillance, and surgical management of hereditary diffuse gastric cancer (HDGC). We began by reviewing the genetics and clinical features of HDGC, an autosomal dominant cancer predisposition syndrome caused primarily by pathogenic variants in CDH1, and less commo

The new National Comprehensive Cancer Network® (NCCN®) Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Esophageal, and Gastric Cancer Guidelines - Version 1.2026 were released on June 16, 2026. Stay tuned for more important updates from the NCCN Guidelines®: Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Esophageal, and Gastric Cancer!

CGA-IGC is pleased to announce a new partnership with Project DNA and the City of Hope to offer educational scholarships totaling $10,000 to support participation in the City of Hope Intensive Course on Genomic Cancer Risk Assessment. These scholarships aim to equip awardees with the skills to deliver genetic risk assessment and testing in their clinical practice, while supporting the development or expansion of genetic testing infrastructure at their home institutions. T

Courtesy of Fight CRC We are thrilled to announce that the ICD-10 Coordination and Maintenance Committee has officially established a specific code for Lynch syndrome, while also allowing a path for the inclusion of BRCA1, BRCA2, and Li-Fraumeni syndrome. Please see Fight CRC’s press release for more details. Thanks to all our members who signed on to Fight CRC's letter to the CDC in support of creating an ICD-10 code for Lynch syndrome. This represents a critical advance

Jennifer Fijor ARNP - CGA-IGC Communication Committee Member CGA-IGC membership brings together the full multidisciplinary hereditary GI cancer care team, including advanced practice providers (APPs). Through CGA-IGC, members gain access to high-quality educational resources and invaluable networking opportunities that foster collaboration across disciplines, creating a truly unique membership experience. Learn more about the vital role APPs play in hereditary GI cancer care.

Ophir Gilad, MD - CGA-IGC Communications Committee Member If you missed our final webinar of the year, or would like to revisit the discussion, the full session is now available on demand for CGA-IGC members. Not yet a member? Join here . This webinar featured Colin Pritchard, MD, PhD , Angela Jacobson, MS, CGC , and Tomas Walsh, PhD , from the University of Washington, who shared exciting updates on advances in genetic testing for hereditary cancers. Dr. Colin Pritchard beg

Hereditary diffuse gastric cancer (HDGC) has long been recognized as one of the most penetrant hereditary cancer syndromes, primarily...

Zachariah H. Foda, MD, PhD, CGA-IGC Communications Committee Member In the latest episode of the CGA-IGC Podcast Series 2025 , host...

Nicholas J. Bartell, M.D - CGA-IGC Communications committee In the newest episode of the CGA-IGC podcast Josie Baker, MS, LGC, genetic...

By Alessandro Mannucci, MD Communications Committee Member The incidence of early-onset colorectal cancer (EOCRC) is rapidly increasing,...

Zachariah H Foda, MD, PhD - CGA-IGC Communications Committee Are you interested in learning how to expand genetic services in your...

Rita Matos, PhD - CGA-IGC Communications Committee If you didn’t have the chance to join us for the final webinar of the year, you can...

Zachariah H Foda, MD, PhD - CGA-IGC Communications Committee In this episode, hosted by Thomas (TJ) Slavin, MD, Medical Geneticist and...

Rita Barbosa-Matos - CGA-IGC Communications Committee As part of #HereditaryCancerAwarenessWeek, we invite you to watch or re-watch our...

Thank you to #CGAIGC committee members, leaders & the wider #HereditaryGICancer community for their contribution to the 2023...

On the occasion of #ColorectalCancerAwarenessMonth we are zooming in on the #eoCRC initiative and the work of the DIRECt group. A...